SCHEMBL1379796

SCHEMBL1379796

COc1cc(-c2cc(-c3cncc(C(=O)NC(C)CO)c3)cn2S(=O)(=O)c2ccc(C)cc2)cc(OC)c1OC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.38
SYK P43405 1/20 0.37
XDH P47989 3/20 0.36
PTGS2 P35354 1/20 0.36
P2RX3 P56373 1/20 0.36
P2RX2 Q9UBL9 1/20 0.36
CTSA P10619 1/20 0.35
TUBB4A P04350 3/20 0.35
TUBB P07437 3/20 0.35
TUBA3C P0DPH7 3/20 0.35
TUBA1B P68363 3/20 0.35
TUBA4A P68366 3/20 0.35
TUBB4B P68371 3/20 0.35
TUBB3 Q13509 3/20 0.35
TUBB2A Q13885 3/20 0.35
TUBB8 Q3ZCM7 3/20 0.35
TUBA3E Q6PEY2 3/20 0.35
TUBA1A Q71U36 3/20 0.35
TUBA1C Q9BQE3 3/20 0.35
TUBB6 Q9BUF5 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3368784 0.86 SYK (0.36) MAPK1SYKXDHCTSAACVR1
SCHEMBL1378422 0.84 MAPT (0.40) ALDH1A1KMT2A
SCHEMBL1376476 0.84 MAP3K11 (0.42) MAPK1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL1376787 0.80 CD274 (0.44) ALDH1A1KMT2A
SCHEMBL1379771 0.80 MAPT (0.37) MAPK1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL1379148 0.79 KDM4E (0.37) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL1378956 0.77 CYP11B1 (0.47) PTGS2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL1379606 0.74 MAP3K11 (0.48) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL1376420 0.71 CA2 (0.61) PTGS2ALDH1A1KMT2A
SCHEMBL3369860 0.71 L3MBTL1 (0.40) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4716996-B2 2011-07-06 JP claimed
EP-1628957-B1 SULFOPYRROLES TAKEDA PHARMACEUTICAL (JP) 2010-09-29 EP claimed
US-20070060570-A1 Sulfopyrroles TALEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-03-15 US claimed
EP-1628957-A1 SULFOPYRROLES Takeda Pharmaceutical Company Limited (JP) 2006-03-01 EP claimed
WO-2004103968-A1 SULFOPYRROLES APONETICS AG (CH) 2004-12-02 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060570-A1 Sulfopyrroles TYK2, ARSA, SULT2A1 MAPK1 1610/4885SYK 64/4885XDH 316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.